Antimicrobial Agents Practice Questions

Q: A patient with severe COVID-19 is treated with an adenosine nucleoside analog antiviral drug that inhibits RNA-dependent RNA polymerase. Which drug is this likely to be?

Remdesivir. ***Remdesivir*** - **Remdesivir** is an **adenosine nucleoside analog** that acts as a **prodrug** and is metabolized intracellularly to its active triphosphate form. - This active form then inhibits **viral RNA-dependent RNA polymerase (RdRp)**, thereby disrupting viral replication in severe **COVID-19**. - It has been the primary established antiviral with WHO recommendation for hospitalized patients with severe COVID-19. *Favipiravir* - **Favipiravir** is a **purine (guanine) analog** antiviral that also targets **RdRp** in RNA viruses. - While it has been explored for COVID-19 in some countries, it is chemically distinct (purine vs. adenosine analog) and lacks the same level of established efficacy evidence for severe COVID-19. - Its primary established use is for **influenza** in some regions (Japan). *Ribavirin* - **Ribavirin** is a guanosine analog with broad-spectrum antiviral activity, often used in combination therapy for **chronic hepatitis C**. - Its mechanism involves interfering with **RNA synthesis** and processing, but it is not a primary treatment for COVID-19. *Oseltamivir* - **Oseltamivir** is a **neuraminidase inhibitor** used to treat and prevent **influenza A and B**. - It works by preventing the release of new viral particles from infected cells, a mechanism distinct from **RdRp inhibition** and unrelated to COVID-19 treatment.

Q: Which macrolide drug is used as a penicillin substitute for patients who are allergic and is known to inhibit protein synthesis?

Azithromycin. ***Azithromycin*** - Azithromycin is a **macrolide antibiotic** that inhibits **bacterial protein synthesis** by binding to the **50S ribosomal subunit**. - It is frequently used as an alternative for patients with a **penicillin allergy**, especially for respiratory tract infections and some sexually transmitted infections. *Vancomycin* - Vancomycin is a **glycopeptide antibiotic** that inhibits **cell wall synthesis** by interfering with peptidoglycan formation, not protein synthesis. - It is primarily used for **MRSA infections** and *Clostridioides difficile* colitis, and is not a common penicillin substitute for general infections. *Clindamycin* - Clindamycin is a **lincosamide antibiotic** that inhibits **protein synthesis** by binding to the **50S ribosomal subunit**, similar to macrolides. - While it can be used in penicillin-allergic patients, its spectrum is more focused on **anaerobic bacteria** and some gram-positive cocci, and it is more associated with *Clostridioides difficile* infection. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone antibiotic** that inhibits bacterial **DNA gyrase** and **topoisomerase IV**, thereby blocking DNA replication. - It does not inhibit protein synthesis and is not typically considered a first-line penicillin substitute for common infections due to its broader spectrum and potential side effects.

Q: Which antifungal drug inhibits ergosterol synthesis and is widely used for systemic fungal infections including candidiasis and cryptococcosis?

Fluconazole. ***Fluconazole*** - Fluconazole is an **azole antifungal** that inhibits **14-alpha-demethylase**, an enzyme crucial for **ergosterol synthesis** in fungal cell membranes, thereby disrupting membrane integrity. - It is effective against a wide range of **systemic fungal infections**, particularly candidiasis, and is known for good oral bioavailability and penetration into the central nervous system. *Terbinafine* - Terbinafine is an **allylamine antifungal** that inhibits **squalene epoxidase**, an early step in ergosterol synthesis, leading to accumulation of toxic squalene. - It is primarily used for **dermatophyte infections** (e.g., onychomycosis) and less commonly for systemic fungal infections. *Amphotericin B* - Amphotericin B is a **polyene antifungal** that directly binds to **ergosterol** in the fungal cell membrane, forming pores and causing leakage of intracellular contents. - It is a **broad-spectrum antifungal** often considered a "last resort" for severe, life-threatening systemic fungal infections due to its significant toxicity. *Caspofungin* - Caspofungin is an **echinocandin antifungal** that inhibits **beta (1,3)-D-glucan synthase**, an enzyme essential for the synthesis of **glucan** in the fungal cell wall, leading to cell wall instability and lysis. - It is effective against *Candida* species and *Aspergillus* but does not target ergosterol synthesis.

Q: Which antiviral drug is most effective in treating hepatitis C due to its direct-acting antiviral mechanism?

Sofosbuvir. ***Sofosbuvir*** - **Sofosbuvir** is a **nucleotide analog inhibitor** that targets the **HCV NS5B RNA polymerase**, a crucial enzyme for viral replication. - It is a cornerstone of **direct-acting antiviral (DAA) regimens** for hepatitis C, achieving high cure rates across various genotypes [1]. *Oseltamivir* - **Oseltamivir** is an **antiviral drug** primarily used to treat and prevent **influenza A and B viruses** by inhibiting neuraminidase. - It has **no activity** against the **hepatitis C virus (HCV)**. *Lamivudine* - **Lamivudine** is a **nucleoside analog reverse transcriptase inhibitor** primarily used to treat **HIV infection** and **chronic hepatitis B virus (HBV) infection** [2]. - While it's an antiviral, it is **not effective** against the **hepatitis C virus (HCV)**. *Acyclovir* - **Acyclovir** is an **antiviral agent** specifically active against **herpes simplex viruses (HSV)** and **varicella-zoster virus (VZV)** by inhibiting viral DNA polymerase. - It has **no therapeutic role** in the treatment of **hepatitis C virus (HCV)** infection.

Q: A patient with a severe penicillin allergy requires treatment for syphilis. Which alternative antibiotic should be considered?

Doxycycline. ***Doxycycline*** - **Doxycycline** is the recommended alternative for treating **syphilis** in patients with a **severe penicillin allergy**. - It is an effective **tetracycline antibiotic** that inhibits protein synthesis in *Treponema pallidum*. - Preferred over cephalosporins in severe allergies due to **no cross-reactivity** with penicillin. *Amoxicillin* - **Amoxicillin** is a **penicillin-class antibiotic** and would be contraindicated in a patient with a severe penicillin allergy due to the risk of allergic reaction. - It works by inhibiting bacterial cell wall synthesis, similar to penicillin. *Ceftriaxone* - **Ceftriaxone** is a **third-generation cephalosporin**, which has a low but present risk of **cross-reactivity** (approximately 1-3%) with penicillin in patients with severe penicillin allergies. - While sometimes used as an alternative in **non-severe** allergies, **doxycycline** is preferred in cases of **severe allergy** due to its lack of cross-reactivity. *Vancomycin* - **Vancomycin** is an antibiotic primarily used for **Gram-positive bacterial infections**, particularly **MRSA**, and is not effective against *Treponema pallidum*. - It works by inhibiting cell wall synthesis, but its spectrum of activity does not cover syphilis effectively.

Q: A patient presents with multidrug-resistant tuberculosis. Which drug, acting as an ATP synthase inhibitor, would be the most appropriate for treatment?

Bedaquiline. ***Bedaquiline*** - Bedaquiline is a diarylquinoline antimycobacterial agent that specifically inhibits **mycobacterial ATP synthase**, a crucial enzyme for energy production in *M. tuberculosis*. - It is a **novel drug approved for multidrug-resistant tuberculosis (MDR-TB)** due to its unique mechanism of action and efficacy against resistant strains. *Rifampin* - Rifampin inhibits **DNA-dependent RNA polymerase**, preventing bacterial RNA synthesis. - While a first-line agent, resistance to rifampin is a defining characteristic of **MDR-TB**, making it inappropriate for this specific scenario. *Isoniazid* - Isoniazid is a **prodrug** that inhibits the synthesis of **mycolic acid**, an essential component of the mycobacterial cell wall. - Resistance to isoniazid is also a key component of **MDR-TB**, rendering it ineffective for this patient. *Ethambutol* - Ethambutol inhibits **arabinosyl transferase**, an enzyme involved in the synthesis of the mycobacterial **cell wall**. - Although it is part of the first-line regimen, it is not an ATP synthase inhibitor, and resistance can develop, which would not address the MDR nature of the infection.

Q: What is the primary mechanism of action of the antifungal drug amphotericin B?

Binding to ergosterol in fungal cell membranes. ***Binding to ergosterol in fungal cell membranes*** - **Amphotericin B** is a **polyene antifungal** that binds specifically to **ergosterol**, a sterol found in fungal cell membranes. - This binding creates **pores** and **channels** in the membrane, leading to increased permeability, leakage of intracellular components, and ultimately **fungal cell death**. *Inhibition of cell wall synthesis* - This mechanism is characteristic of antifungal drugs like **echinocandins** (e.g., caspofungin), which target **β-(1,3)-D-glucan synthesis**. - Amphotericin B does not affect the fungal cell wall, but rather acts on the cell membrane. *Inhibition of nucleic acid synthesis* - This mechanism is primarily associated with antifungals like **flucytosine**, which is converted into a cytotoxic metabolite that interferes with DNA and RNA synthesis. - Amphotericin B does not directly inhibit the synthesis of genetic material. *Inhibition of protein synthesis* - While some **antibiotics** (e.g., tetracyclines, aminoglycosides) target bacterial protein synthesis, this is not a primary mechanism of action for antifungal drugs. - Antifungals generally act on unique fungal structures or metabolic pathways.

Q: Which antifungal agent is considered the most effective for treating invasive mucormycosis in immunocompromised patients?

Amphotericin B. ***Amphotericin B*** - **Amphotericin B**, particularly its lipid formulations, is considered the **first-line and most effective antifungal agent** for the treatment of invasive mucormycosis due to its broad spectrum of activity against Mucorales. - It works by binding to **ergosterol** in the fungal cell membrane, leading to pore formation and cell death, which is critical for rapidly progressive infections like mucormycosis. *Voriconazole* - **Voriconazole** is highly effective against *Aspergillus* and *Candida* species but has **minimal or no activity** against the **Mucorales** fungi that cause mucormycosis. - Using voriconazole for mucormycosis could lead to treatment failure and progression of the disease due to its **lack of efficacy** against this specific fungal group. *Fluconazole* - **Fluconazole** is a narrow-spectrum azole primarily used for *Candida* infections, particularly *Candida albicans*, and has **no activity** against **Mucorales** species. - Therefore, it is completely **ineffective** for treating invasive mucormycosis and should not be used. *Itraconazole* - While **itraconazole** has a broader spectrum than fluconazole and some activity against certain molds, it has **limited or unreliable activity** against **Mucorales** and is not recommended for invasive mucormycosis. - Its **pharmacokinetic profile** and drug interactions also make it less suitable as a primary agent for severe, life-threatening infections like mucormycosis compared to amphotericin B.

Q: A patient with a history of genital herpes presents with a new cluster of vesicles on the labia. Which medication is the most appropriate for the treatment of this condition?

Valacyclovir. ***Valacyclovir*** - It is a **prodrug of acyclovir** with improved oral bioavailability (54% vs 15-20%), allowing for less frequent dosing (typically twice daily) and better patient adherence. - **Valacyclovir** is highly effective in treating recurrent **genital herpes infections**, reducing the duration and severity of outbreaks by 1-2 days when started early. - **Most convenient dosing regimen** for suppressive therapy (500 mg once daily) makes it a preferred choice in clinical practice. *Incorrect: Acyclovir* - While effective for **genital herpes** and the original drug for HSV treatment, it has lower oral bioavailability (15-20%) compared to valacyclovir. - Requires **more frequent dosing** (200 mg five times daily or 400 mg three times daily for acute outbreaks), which can lead to reduced patient adherence. - Still an acceptable alternative, especially where cost is a consideration. *Incorrect: Famciclovir* - Famciclovir is a **prodrug of penciclovir** and is also effective for HSV infections with good bioavailability (77%). - Dosing is typically **250 mg three times daily** for acute outbreaks or 250 mg twice daily for suppression. - Clinically equivalent efficacy to valacyclovir, but slightly less convenient dosing schedule makes valacyclovir marginally preferred. *Incorrect: Ganciclovir* - Ganciclovir is primarily indicated for **cytomegalovirus (CMV) infections**, particularly in immunocompromised patients. - **Not recommended as first-line therapy** for HSV infections due to significant toxicity (bone marrow suppression) and the availability of safer, more effective alternatives. - Reserved for severe, acyclovir-resistant HSV cases in immunocompromised patients.

Q: Which of the following antibiotics is classified as a macrolide and is used for respiratory tract infections due to its effective activity against atypical bacteria?

Azithromycin. ***Azithromycin*** - Azithromycin is a **macrolide antibiotic** known for its excellent activity against **atypical bacteria** such as *Mycoplasma pneumoniae*, *Chlamydophila pneumoniae*, and *Legionella pneumophila*, which are common causes of respiratory tract infections. - Its **long half-life** allows for once-daily dosing and shorter courses of therapy, making it a preferred choice for community-acquired pneumonia and other respiratory infections. *Ceftriaxone* - Ceftriaxone is a **third-generation cephalosporin antibiotic**, not a macrolide, primarily targeting **gram-positive** and **gram-negative bacteria**. - While effective against many respiratory pathogens, it has **limited activity against atypical bacteria**, unlike macrolides. *Ciprofloxacin* - Ciprofloxacin is a **fluoroquinolone antibiotic**, not a macrolide, with a broad spectrum of activity against **gram-negative bacteria** and some **atypical bacteria**. - While effective for some respiratory infections, its mechanism of action and classification differ significantly from macrolides. *Vancomycin* - Vancomycin is a **glycopeptide antibiotic** primarily used for **serious gram-positive infections**, particularly those caused by **methicillin-resistant *Staphylococcus aureus* (MRSA)**. - It is **not effective against atypical bacteria** and is generally reserved for more severe or resistant infections, not typically first-line for common respiratory tract infections.

Question 1

A patient with severe COVID-19 is treated with an adenosine nucleoside analog antiviral drug that inhibits RNA-dependent RNA polymerase. Which drug is this likely to be?

Accepted Answer

Remdesivir

Answer

Favipiravir

Answer

Ribavirin

Answer

Oseltamivir

Question 2

Which macrolide drug is used as a penicillin substitute for patients who are allergic and is known to inhibit protein synthesis?

Accepted Answer

Azithromycin

Answer

Vancomycin

Answer

Ciprofloxacin

Answer

Clindamycin

Question 3

Which antifungal drug inhibits ergosterol synthesis and is widely used for systemic fungal infections including candidiasis and cryptococcosis?

Accepted Answer

Fluconazole

Answer

Terbinafine

Answer

Amphotericin B

Answer

Caspofungin

Question 4

Which antiviral drug is most effective in treating hepatitis C due to its direct-acting antiviral mechanism?

Accepted Answer

Sofosbuvir

Answer

Oseltamivir

Answer

Lamivudine

Answer

Acyclovir

Question 5

A patient with a severe penicillin allergy requires treatment for syphilis. Which alternative antibiotic should be considered?

Accepted Answer

Doxycycline

Answer

Amoxicillin

Answer

Ceftriaxone

Answer

Vancomycin

Question 6

A patient presents with multidrug-resistant tuberculosis. Which drug, acting as an ATP synthase inhibitor, would be the most appropriate for treatment?

Accepted Answer

Bedaquiline

Answer

Rifampin

Answer

Isoniazid

Answer

Ethambutol

Question 7

What is the primary mechanism of action of the antifungal drug amphotericin B?

Accepted Answer

Binding to ergosterol in fungal cell membranes

Answer

Inhibition of cell wall synthesis

Answer

Inhibition of nucleic acid synthesis

Answer

Inhibition of protein synthesis

Question 8

Which antifungal agent is considered the most effective for treating invasive mucormycosis in immunocompromised patients?

Accepted Answer

Amphotericin B

Answer

Voriconazole

Answer

Fluconazole

Answer

Itraconazole

Question 9

A patient with a history of genital herpes presents with a new cluster of vesicles on the labia. Which medication is the most appropriate for the treatment of this condition?

Accepted Answer

Valacyclovir

Answer

Acyclovir

Answer

Famciclovir

Answer

Ganciclovir

Question 10

Which of the following antibiotics is classified as a macrolide and is used for respiratory tract infections due to its effective activity against atypical bacteria?

Accepted Answer

Azithromycin

Answer

Ceftriaxone

Answer

Ciprofloxacin

Answer

Vancomycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?